{"id":15503,"date":"2012-09-30T11:30:00","date_gmt":"2012-09-30T09:30:00","guid":{"rendered":"http:\/\/www.fedaiisf.it\/andamento-delle-segnalazioni-di-sospette-reazioni-avverse-in-italia\/"},"modified":"2012-09-30T11:30:00","modified_gmt":"2012-09-30T09:30:00","slug":"andamento-delle-segnalazioni-di-sospette-reazioni-avverse-in-italia","status":"publish","type":"post","link":"https:\/\/www.fedaiisf.it\/en\/andamento-delle-segnalazioni-di-sospette-reazioni-avverse-in-italia\/","title":{"rendered":"Trend of reports of suspected adverse reactions in Italy"},"content":{"rendered":"<p style=\"text-align: left\"><em><span style=\"font-size: medium\">L&rsquo;Agenzia Italiana del Farmaco in collaborazione con i Centri Regionali di <\/span><\/em><em><a class=\"glossary-term\" href=\"http:\/\/www.agenziafarmaco.gov.it\/it\/glossary\/term\/1454\" target=\"_blank\" rel=\"noopener\"><span style=\"font-size: medium\"><dfn title=\"Complex of activities aimed at continuously evaluating all information relating to the safety of medicines and ensuring, for all medicines on the market, a favorable benefit\/risk ratio for the population.\">Pharmacovigilance<\/dfn><\/span><\/a><span style=\"font-size: medium\">* (CRFV) rende disponibile on line una <\/span><\/em><a target=\"_blank\" href=\"http:\/\/www.agenziafarmaco.gov.it\/sites\/default\/files\/and_segn_2011_11052012def.pdf\" rel=\"noopener\"><em><span style=\"font-size: medium\">presentation<\/span><\/em><\/a><em><span style=\"font-size: medium\"> sull&#8217;andamento delle segnalazioni di sospette reazioni avverse registrate nella Rete Nazionale di <\/span><\/em><em><a class=\"glossary-term\" href=\"http:\/\/www.agenziafarmaco.gov.it\/it\/glossary\/term\/1454\" target=\"_blank\" rel=\"noopener\"><span style=\"font-size: medium\"><dfn title=\"Complex of activities aimed at continuously evaluating all information relating to the safety of medicines and ensuring, for all medicines on the market, a favorable benefit\/risk ratio for the population.\">Pharmacovigilance<\/dfn><\/span><\/a><span style=\"font-size: medium\"> dal 2001 al 2011.<br \/> L&#8217;obiettivo &egrave; quello di fornire un feedback a tutti quei segnalatori che con il loro impegno hanno contribuito e continuano a contribuire al mantenimento e al miglioramento del sistema della <\/span><\/em><em><a class=\"glossary-term\" href=\"http:\/\/www.agenziafarmaco.gov.it\/it\/glossary\/term\/1454\" target=\"_blank\" rel=\"noopener\"><span style=\"font-size: medium\"><dfn title=\"Complex of activities aimed at continuously evaluating all information relating to the safety of medicines and ensuring, for all medicines on the market, a favorable benefit\/risk ratio for the population.\">pharmacovigilance<\/dfn><\/span><\/a><span style=\"font-size: medium\">.<\/span><\/em><\/p>\n<p style=\"text-align: left\"><a target=\"_blank\" href=\"http:\/\/www.agenziafarmaco.gov.it\/sites\/default\/files\/and_segn_2011_11052012def.pdf\" rel=\"noopener\"><span style=\"font-size: medium\"><em>Leggere il documento in allegato<\/em><\/span><\/a><\/p>\n<p style=\"text-align: left\"><span style=\"font-size: medium\"><img decoding=\"async\" class=\"filefield-icon field-icon-application-pdf\" alt=\"application\/pdf icon\" src=\"http:\/\/www.agenziafarmaco.gov.it\/sites\/all\/modules\/filefield\/icons\/application-pdf.png\" \/><\/span><a title=\"and_segn_2011_11052012def.pdf\" type=\"application\/pdf; length=166574\" href=\"http:\/\/www.agenziafarmaco.gov.it\/sites\/default\/files\/and_segn_2011_11052012def.pdf\" target=\"_blank\" rel=\"noopener\"><span style=\"font-size: medium\">Andamento segnalazioni 2001 \/ 2011<\/span><\/a><\/p>\n<p class=\"MsoNormal\" style=\"text-align: left; line-height: normal; text-indent: -18pt; margin: 0cm 0cm 10pt 18pt; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; mso-list: l0 level1 lfo1; tab-stops: list 36.0pt\"><span style=\"font-family: Symbol; font-size: 10pt; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol; mso-fareast-language: IT; mso-bidi-font-size: 12.0pt\"><span style=\"mso-list: Ignore\">\u00b7<span style=\"font: 7pt &quot;Times New Roman&quot;\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <\/span><\/span><\/span><span style=\"font-family: &quot;Times New Roman&quot;,&quot;serif&quot;; font-size: 12pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: IT\">Prescription for <a href=\"http:\/\/www.agenziafarmaco.gov.it\/it\/glossary\/term\/1471\" target=\"_blank\" rel=\"noopener\"><i><span style=\"color: #008800; text-decoration: none; text-underline: none\">active principle<\/span><\/i><\/a><\/p>\n<p><\/span><\/p>\n<p class=\"MsoNormal\" style=\"text-align: left; line-height: normal; margin: 0cm 0cm 10pt 18pt; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; mso-outline-level: 3\"><b><span","protected":false},"excerpt":{"rendered":"<p>L&rsquo;Agenzia Italiana del Farmaco in collaborazione con i Centri Regionali di Farmacovigilanza* (CRFV) rende disponibile on line una presentazione sull&#8217;andamento delle segnalazioni di sospette reazioni avverse registrate nella Rete Nazionale di Farmacovigilanza dal 2001 al 2011. L&#8217;obiettivo &egrave; quello di fornire un feedback a tutti quei segnalatori che con il loro impegno hanno contribuito e &hellip;<\/p>","protected":false},"author":1,"featured_media":9846,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[90],"tags":[],"class_list":["post-15503","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-fedaiisf-archivio-storico"],"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/15503","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/comments?post=15503"}],"version-history":[{"count":0,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/15503\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media\/9846"}],"wp:attachment":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media?parent=15503"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/categories?post=15503"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/tags?post=15503"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}